Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Las Vegas, Nevada
- Most recent report
- 8-K, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 176 filings
- On EDGAR
- CIK 1575142
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 46
News 8 of 32
- 8-K Significant contract Nov 4, 2026
- 8-K Current report on a material event Mar 18, 2025
- 8-K Leadership change Feb 7, 2025
- 8-K Current report on a material event Dec 5, 2024
- 8-K Current report on a material event Nov 27, 2024
- 8-K Other events Nov 20, 2024
- 8-K Other events Oct 30, 2024
- 8-K Leadership change May 22, 2024
Prospectuses and Registrations 4
Ownership 8 of 33
- 4 Insider reported a trade Nov 4, 2026
- 4 Insider reported a trade Oct 6, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Aug 4, 2026
- 4 Insider reported a trade Jul 6, 2026
- 4 Insider reported a trade Jun 3, 2026
- 4 Insider reported a trade May 5, 2026
- 4 Insider reported a trade Apr 3, 2026
Other 8 of 61
- NT 10-Q Notice that a quarterly report will be late Aug 14, 2026
- NT 10-K Notice that an annual report will be late Mar 31, 2026
- NT 10-K Notice that an annual report will be late Mar 31, 2025
- DEF 14C Mar 28, 2025
- DEF 14C Mar 14, 2025
- SEC STAFF ACTION Feb 24, 2025
- NT 10-Q Notice that a quarterly report will be late Nov 14, 2024
- NT 10-Q Notice that a quarterly report will be late Aug 15, 2024
Everything here comes from Bioadaptives, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.